File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1601-6343.2007.00381.x
- Scopus: eid_2-s2.0-34047177517
- PMID: 17284242
- WOS: WOS:000253382300001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The use of recombinant adeno-associated virus for skeletal gene therapy.
Title | The use of recombinant adeno-associated virus for skeletal gene therapy. |
---|---|
Authors | |
Keywords | Adeno-associated virus Cartilage Gene therapy Mandible Rheumatoid arthritis Temporomandibular joint |
Issue Date | 2007 |
Publisher | Wiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=1601-6335&site=1 |
Citation | Orthodontics & Craniofacial Research, 2007, v. 10 n. 1, p. 1-14 How to Cite? |
Abstract | OBJECTIVES: To provide a comprehensive literature review describing recent developments of the recombinant adeno-associated virus (rAAV) vector and exploring the therapeutic application of rAAV for bone defects, cartilage lesions and rheumatoid arthritis. DESIGN: Narrative review. RESULT: The review outlines the serotypes and genome of AAV, integration and life cycle of the rAAV vectors, the immune response and regulating system for AAV gene therapy. Furthermore, the advancements of rAAV gene therapy for bone growth together with cartilage repair are summarized. CONCLUSION: Recombinant adeno-associated virus vector is perceived to be one of the most promising vector systems for bone and cartilage gene therapy approaches and further investigations need to be carried out for craniofacial research. |
Persistent Identifier | http://hdl.handle.net/10722/144273 |
ISSN | 2023 Impact Factor: 2.4 2023 SCImago Journal Rankings: 0.967 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dai, J | en_HK |
dc.contributor.author | Rabie, AB | en_HK |
dc.date.accessioned | 2012-01-20T08:58:40Z | - |
dc.date.available | 2012-01-20T08:58:40Z | - |
dc.date.issued | 2007 | en_HK |
dc.identifier.citation | Orthodontics & Craniofacial Research, 2007, v. 10 n. 1, p. 1-14 | en_HK |
dc.identifier.issn | 1601-6335 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/144273 | - |
dc.description.abstract | OBJECTIVES: To provide a comprehensive literature review describing recent developments of the recombinant adeno-associated virus (rAAV) vector and exploring the therapeutic application of rAAV for bone defects, cartilage lesions and rheumatoid arthritis. DESIGN: Narrative review. RESULT: The review outlines the serotypes and genome of AAV, integration and life cycle of the rAAV vectors, the immune response and regulating system for AAV gene therapy. Furthermore, the advancements of rAAV gene therapy for bone growth together with cartilage repair are summarized. CONCLUSION: Recombinant adeno-associated virus vector is perceived to be one of the most promising vector systems for bone and cartilage gene therapy approaches and further investigations need to be carried out for craniofacial research. | en_HK |
dc.language | eng | en_US |
dc.publisher | Wiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=1601-6335&site=1 | en_HK |
dc.relation.ispartof | Orthodontics & craniofacial research | en_HK |
dc.subject | Adeno-associated virus | - |
dc.subject | Cartilage | - |
dc.subject | Gene therapy | - |
dc.subject | Mandible | - |
dc.subject | Rheumatoid arthritis | - |
dc.subject | Temporomandibular joint | - |
dc.subject.mesh | Arthritis, Rheumatoid - therapy | en_HK |
dc.subject.mesh | Bone Diseases - therapy | en_HK |
dc.subject.mesh | Cartilage Diseases - therapy | en_HK |
dc.subject.mesh | DNA, Recombinant - genetics - therapeutic use | en_HK |
dc.subject.mesh | Dependovirus - genetics | en_HK |
dc.subject.mesh | Gene Therapy - methods | en_HK |
dc.subject.mesh | Genetic Vectors - genetics | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Virus Integration - genetics | en_HK |
dc.title | The use of recombinant adeno-associated virus for skeletal gene therapy. | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Dai, J: | en_HK |
dc.identifier.email | Rabie, AB: rabie@hku.hk | en_HK |
dc.identifier.authority | Dai, J=rp01569 | en_HK |
dc.identifier.authority | Rabie, AB=rp00029 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1111/j.1601-6343.2007.00381.x | en_HK |
dc.identifier.pmid | 17284242 | - |
dc.identifier.scopus | eid_2-s2.0-34047177517 | en_HK |
dc.identifier.hkuros | 135846 | - |
dc.identifier.volume | 10 | en_HK |
dc.identifier.issue | 1 | en_HK |
dc.identifier.spage | 1 | en_HK |
dc.identifier.epage | 14 | en_HK |
dc.identifier.isi | WOS:000253382300001 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Dai, J=35387686200 | en_HK |
dc.identifier.scopusauthorid | Rabie, AB=7007172734 | en_HK |
dc.identifier.issnl | 1601-6335 | - |